Literature DB >> 21343676

Ascorbic acid enhances radiation-induced apoptosis in an HL60 human leukemia cell line.

Koji Shinozaki1, Yoichiro Hosokawa, Masakatsu Hazawa, Ikuo Kashiwakura, Kazuhiko Okumura, Tohru Kaku, Eiji Nakayama.   

Abstract

This study was conducted to examine the utility of the combined use of ascorbic acid (AsA) and radiation in clinical applications. We investigated cell survival, DNA fragmentation, and caspase activation after X-ray irradiation and AsA treatment of human leukemia HL60 cells. The number of living cells decreased after combined X-ray irradiation and AsA treatment (2 Gy + 5 mM) in comparison with that after X-ray irradiation (2 Gy) or AsA treatment (5 mM) alone. DNA fragmentation was more in the cells subjected to combined X-ray irradiation and AsA treatment than in those subjected to X-ray irradiation alone. Caspase-3, caspase-8, and caspase-9 were highly activated following combined X-ray irradiation and AsA treatment, but caspase-8 activity was not markedly increased after X-ray irradiation alone. Bax levels in the mitochondrial membrane fractions were increased after AsA treatment alone and after combined X-ray irradiation and AsA treatment. However, there was no apparent increase in the Bax levels after X-ray irradiation treatment alone. Thus, this study confirmed that supplementing X-ray irradiation with AsA treatment results in increased apoptosis in HL60 cells. With regard to the apoptosis-inducing factors, we hypothesized that Bax and caspase-8 were activated after combined X-ray irradiation and AsA treatment compared with either treatment alone.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21343676     DOI: 10.1269/jrr.10089

Source DB:  PubMed          Journal:  J Radiat Res        ISSN: 0449-3060            Impact factor:   2.724


  14 in total

1.  Fluorine-18-Labeled Thymidine Positron Emission Tomography (FLT-PET) as an Index of Cell Proliferation after Pharmacological Ascorbate-Based Therapy.

Authors:  John A Cieslak; Zita A Sibenaller; Susan A Walsh; Laura L Boles Ponto; Juan Du; John J Sunderland; Joseph J Cullen
Journal:  Radiat Res       Date:  2015-12-31       Impact factor: 2.841

Review 2.  Parenteral ascorbate as a cancer therapeutic: a reassessment based on pharmacokinetics.

Authors:  Nermi L Parrow; Jonathan A Leshin; Mark Levine
Journal:  Antioxid Redox Signal       Date:  2013-06-19       Impact factor: 8.401

3.  Ascorbic acid does not reduce the anticancer effect of radiotherapy.

Authors:  Yoichiro Hosokawa; Ryo Saga; Satoru Monzen; Shingo Terashima; Eichi Tsuruga
Journal:  Biomed Rep       Date:  2016-11-29

4.  Pharmacological Ascorbate Radiosensitizes Pancreatic Cancer.

Authors:  Juan Du; John A Cieslak; Jessemae L Welsh; Zita A Sibenaller; Bryan G Allen; Brett A Wagner; Amanda L Kalen; Claire M Doskey; Robert K Strother; Anna M Button; Sarah L Mott; Brian Smith; Susan Tsai; James Mezhir; Prabhat C Goswami; Douglas R Spitz; Garry R Buettner; Joseph J Cullen
Journal:  Cancer Res       Date:  2015-06-16       Impact factor: 12.701

Review 5.  Treatment of Pancreatic Cancer with Pharmacological Ascorbate.

Authors:  John A Cieslak; Joseph J Cullen
Journal:  Curr Pharm Biotechnol       Date:  2015       Impact factor: 2.837

Review 6.  ROS-modulated therapeutic approaches in cancer treatment.

Authors:  Muhammad Hassan Raza; Sami Siraj; Abida Arshad; Usman Waheed; Fahad Aldakheel; Shatha Alduraywish; Muhammad Arshad
Journal:  J Cancer Res Clin Oncol       Date:  2017-06-24       Impact factor: 4.553

7.  Pharmacological ascorbate and ionizing radiation (IR) increase labile iron in pancreatic cancer.

Authors:  Justin C Moser; Malvika Rawal; Brett A Wagner; Juan Du; Joseph J Cullen; Garry R Buettner
Journal:  Redox Biol       Date:  2013-11-26       Impact factor: 11.799

Review 8.  Micronutrients in Oncological Intervention.

Authors:  Uwe Gröber; Peter Holzhauer; Klaus Kisters; Michael F Holick; Irenäus A Adamietz
Journal:  Nutrients       Date:  2016-03-12       Impact factor: 5.717

9.  Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients.

Authors:  Nina Mikirova; Joseph Casciari; Neil Riordan; Ronald Hunninghake
Journal:  J Transl Med       Date:  2013-08-15       Impact factor: 5.531

10.  A combination of pre- and post-exposure ascorbic acid rescues mice from radiation-induced lethal gastrointestinal damage.

Authors:  Yasutoshi Ito; Manabu Kinoshita; Tetsuo Yamamoto; Tomohito Sato; Takeyuki Obara; Daizoh Saitoh; Shuhji Seki; Yukihiro Takahashi
Journal:  Int J Mol Sci       Date:  2013-09-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.